Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
September 29, 2016 – Teva announced the FDA approval of an AB-rated generic version of ViiV Healthcare’s Epzicom (abacavir/lamivudine) 600 mg/300 mg tablets.
